Rheumatoid arthritis (RA) is characterized by chronic inflammation of the synovial tissues. A hallmark of the inflammatory process is the accumulation of mononuclear cells in the inflamed synovium. It has become increasingly clear that lymphocytes enter sites of inflammation following specific receptor-mediated binding and transendothelial migration. Whether specific subsets of lymphocytes are uniquely recruited to enter inflammatory sites has not been explored in detail. It is hypothesized that specific lymphocyte populations, exhibiting a distinctive phenotypic and functional capacity, preferentially migrate into sites of inflammation. The proposed studies will utilize in vitro transendothelial migration assays to identify T lymphocytes that express a migratory capacity. The distinguishing characteristics of these lymphocyte subsets will be identified. Further studies will examine the mechanisms mediating transendothelial migration and will examine the functional capacities of these cells as well. In addition to T cells, B cells accumulate in rheumatoid synovial tissue, although the adhesion mechanisms utilized by B cells are not well understood. The proposed studies will examine the adhesion and transendothelial migration of B cells. We will determine whether specific B cell populations express a migratory behavior and whether this can account for the accumulation of B cells in inflammatory sites. The proposed studies will also examine the signals generated in T cells and endothelial cells (EC) following the cell-cell interactions. We will utilize soluble forms of adhesion receptors to delineate the mechanisms induced in T cells and EC which may regulate the transendothelial migration of T cells. Finally, the proposed studies will characterize in detail the migratory behavior of lymphocytes isolated from RA patients and compare it with that of normals. The proposed research should provide a comprehensive view of the mechanisms governing migration of T and B lymphocytes into rheumatoid synovium, and should provide information concerning the hypothesis that migratory capacity accounts for the cells found in the inflammatory tissue.

Project Start
1996-09-01
Project End
1998-08-31
Budget Start
Budget End
Support Year
10
Fiscal Year
1997
Total Cost
Indirect Cost
City
Dallas
State
TX
Country
United States
Zip Code
75390
Rosloniec, Edward F; Whittington, Karen B; He, Xiaowen et al. (2004) Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401). Am J Med Sci 327:169-79
Hayashida, K; Nanki, T; Girschick, H et al. (2001) Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthritis Res 3:118-26
Nanki, T; Lipsky, P E (2001) Stimulation of T-Cell activation by CXCL12/stromal cell derived factor-1 involves a G-protein mediated signaling pathway. Cell Immunol 214:145-54
Nanki, T; Lipsky, P E (2000) Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation. J Immunol 164:5010-4
Nanki, T; Lipsky, P E (2000) Lack of correlation between chemokine receptor and T(h)1/T(h)2 cytokine expression by individual memory T cells. Int Immunol 12:1659-67
Hayashida, K; Shimaoka, Y; Ochi, T et al. (2000) Rheumatoid arthritis synovial stromal cells inhibit apoptosis and up-regulate Bcl-xL expression by B cells in a CD49/CD29-CD106-dependent mechanism. J Immunol 164:1110-6
He, X; Stuart, J M (1999) Prostaglandin E2 selectively inhibits human CD4+ T cells secreting low amounts of both IL-2 and IL-4. J Immunol 163:6173-9
Brezinschek, R I; Oppenheimer-Marks, N; Lipsky, P E (1999) Activated T cells acquire endothelial cell surface determinants during transendothelial migration. J Immunol 162:1677-84
Davis, L S; Lipsky, P E (1998) Disordered differentiation of memory T cells in rheumatoid arthritis. Rev Rhum Engl Ed 65:291-6
Oppenheimer-Marks, N; Brezinschek, R I; Mohamadzadeh, M et al. (1998) Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest 101:1261-72

Showing the most recent 10 out of 104 publications